These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35786718)

  • 1. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
    Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
    Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
    Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
    Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in
    Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M
    Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
    Shammas MK; Huang TH; Narendra DP
    Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.
    Liao SC; Kano K; Phanse S; Nguyen M; Margolis E; Fu Y; Meng J; Moutaoufik MT; Chatterton Z; Aoki H; Simms J; Hsieh I; Suteja F; Sei Y; Huang EJ; McAvoy K; Manfredi G; Halliday G; Babu M; Nakamura K
    bioRxiv; 2024 Aug; ():. PubMed ID: 39257750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Imai Y; Meng H; Shiba-Fukushima K; Hattori N
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
    Kee TR; Espinoza Gonzalez P; Wehinger JL; Bukhari MZ; Ermekbaeva A; Sista A; Kotsiviras P; Liu T; Kang DE; Woo JA
    Front Aging Neurosci; 2021; 13():660843. PubMed ID: 33967741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
    Zhou W; Ma D; Tan EK
    Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
    [No Abstract]   [Full Text] [Related]  

  • 14. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
    Ruan Y; Hu J; Che Y; Liu Y; Luo Z; Cheng J; Han Q; He H; Zhou Q
    Cell Death Dis; 2022 Feb; 13(2):156. PubMed ID: 35173147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.
    Sato S; Noda S; Torii S; Amo T; Ikeda A; Funayama M; Yamaguchi J; Fukuda T; Kondo H; Tada N; Arakawa S; Watanabe M; Uchiyama Y; Shimizu S; Hattori N
    Hum Mol Genet; 2021 Apr; 30(6):443-453. PubMed ID: 33631794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response.
    Petel Légaré V; Rampal CJ; Gurberg TJN; Aaltonen MJ; Janer A; Zinman L; Shoubridge EA; Armstrong GAB
    Dev Neurobiol; 2023 Jan; 83(1-2):54-69. PubMed ID: 36799027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
    Ren YL; Jiang Z; Wang JY; He Q; Li SX; Gu XJ; Qi YR; Zhang M; Yang WJ; Cao B; Li JY; Wang Y; Chen YP
    Mol Neurobiol; 2024 Oct; 61(10):7968-7988. PubMed ID: 38453793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
    Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
    J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
    Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
    Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
    Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
    Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.